- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.07. | Real-world evidence as a strategic access lever in rare disease drug development | ||
| 11.07. | The unsustainability of clinical trials and need for transformative change | ||
| 11.07. | IGI and AbbVie sign licence deal for cancer and autoimmune therapy | ||
| 10.07. | Enhancing solubility of targeted protein degraders: Better strategies for bioavailability | ||
| 10.07. | CTO East Coast 2025: Global oncology cell therapy market to hit $25bn by 2031 | ||
| 10.07. | How to remain a top CDMO in ADC-led oncology | ||
| 10.07. | Lupin and Zentiva in licence and supply deal for Certolizumab Pegol | ||
| 10.07. | Merck agrees to acquire Verona Pharma for $10bn | ||
| 09.07. | Trump's 200% tariff threat could send shockwaves through pharma supply chains | ||
| 09.07. | Niagen Bioscience signs exclusive licence deal for PD therapy | ||
| 09.07. | JCR Pharma and Alexion partner on JUST-AAV gene therapy platform | ||
| 09.07. | CTO East Coast 2025: Navigating shifting regulatory environment hinges on close alignment | ||
| 09.07. | Research warns of rising HIV cases in Africa amid global funding cuts | ||
| 09.07. | Swissmedic approves IFINWIL for children with high-risk neuroblastoma | ||
| 08.07. | Chugai and Gero link on antibody drugs for age-related conditions | ||
| 08.07. | Leading medical groups sue RFK Jr and HHS over 'hostile' vaccine policies | ||
| 08.07. | Pulmonary arterial hypertension market to reach $9.35bn across 7MM by 2034 | ||
| 08.07. | Swissmedic approves Novartis' malaria medicine for babies | ||
| 08.07. | GSK acquires efimosfermin alfa from Boston Pharma for $2bn | ||
| 07.07. | FDA approves KalVista's Ekterly for hereditary angioedema | ||
| 07.07. | J&J eyes prostate cancer label expansion for Akeega | ||
| 07.07. | DoH and Children's National Hospital link for cell and gene therapy | ||
| 07.07. | Alembic Pharmaceuticals acquires UTILITY therapeutics | ||
| 07.07. | CDMO insights podcast series: Our Experience is Your Strength | Episode #1 Formulation | ||
| 04.07. | Five lessons from biopharma companies' data transformation journeys |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .